DURHAM — The CEO of Iqvia Holdings Inc. was paid $16.5 million in total compensation in 2018, down  $21.5 million from his $38 million compensation in 2017.

Ari Bousbib

That’s a 56.6 percent decrease in compensation.

The Durham-based health information technologies and clinical research company named Ari Bousbib its CEO in October 2016 after the merger of Quintiles and IMS Health.

From 2010 until the merger, Bousbib was chairman and CEO of IMS Health.

A filing with the Securities and Exchange Commission  Thursday shows the largest decrease coming from the CEO’s stock awards. He was awarded $26.4 million in stock awards in 2017 and only $3.9 million in 2018.

Bousbib’s base salary was $1.6 million in 2018, the same as it was in 2017.

He received $3.6 million in option awards in 2018 compared to $3 million in option awards in 2017.

Iqvia stock closed at $142.02 Thursday, up 83 cents from close Wednesday.

This story is from the North Carolina Business News Wire, a service of the UNC-Chapel Hill School of Media and Journalism

IQVIA unveils new unit to support small life science firms

In a simple SEC filing, IQVIA says Quintiles founder Dennis Gillings has retired